Document is current
Any future updates will be listed below
-
Authors
Pati, Avik K. https://orcid.org/0000-0001-5539-7031
Kilic, Zeliha https://orcid.org/0000-0002-3287-9561
Martin, Maxwell I.
Terry, Daniel S.
Borgia, Alessandro https://orcid.org/0000-0002-4701-8967
Bar, Sukanta https://orcid.org/0000-0002-8473-1657
Jockusch, Steffen https://orcid.org/0000-0002-4592-5280
Kiselev, Roman https://orcid.org/0000-0003-3290-6221
Altman, Roger B.
Blanchard, Scott C. https://orcid.org/0000-0003-2717-9365
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM098859)
National Institutes of Health
- License Information
-
More Information
Article History
Received: 29 March 2023
Accepted: 25 April 2024
First Online: 14 June 2024
Competing interests
: S.C.B. and R.B.A. have an equity interest in Lumidyne Technologies. The remaining authors declare no competing interests.
